58 -12 (74) 2024 - Karimdjanova G.A., Egamberdieva D.A. - TO STUDY THE RELATIONSHIP BETWEEN ATRIAL FIBRILLATION AND BIOMARKERS OF INFLAMMATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

TO STUDY THE RELATIONSHIP BETWEEN ATRIAL FIBRILLATION AND BIOMARKERS OF INFLAMMATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Karimdjanova G.A. - Tashkent Pediatric Medical Institute

Egamberdieva D.A. - Tashkent Pediatric Medical Institute

Resume

The article also discusses biomarkers of inflammation in patients with chronic obstructive pulmonary disease (COPD) and atrial fibrillation (AF). It was found that age, hypertension, chronic heart failure and COPD stage are significant risk factors for the development of AF. Coagulation and inflammatory biomarkers were significantly higher in patients with COPD and AF, indicating systemic inflammation and the risk of thrombosis

Keywords: chronic obstructive pulmonary disease, atrial fibrillation, cardiovascular disease, dopplerography, endothelial dysfunction

First page

300

Last page

303

For citation:Karimdjanova G.A, Egamberdieva D.A. - TO STUDY THE RELATIONSHIP BETWEEN ATRIAL FIBRILLATION AND BIOMARKERS OF INFLAMMATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE//New Day in Medicine 12(74)2024 300-303 https://https://newdayworldmedicine.com/en/new_day_medicine/12-74-2024

List of References

1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J i sar. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research. Clinical Cardiology and Epidemiology and Prevention. Circulation. 2003; 110(12):1514–1517.
2. Nelson K, Thethi I, Cunanan J, Hoppensteadt D, Bajwa R, Fareed J, Bansal V. Upregulation of surogate markers of inflamation and thrombogenesis in patients with ESRD: pathophysiologic and therapeutic implications. Clin Appl Thromb Hemost. 2011; 17(3):302–304.
3. Chaykovska L, Tsuprykov O, Hocher B. Biomarkers for the prediction of mortality and morbidity in patients with renal replasement therapy. Clin Lab. 2011; 57(7-8):455–467.
4. Wattanakit K, Cushman M. Chronic Kidney Disease and Venous Thromboembolism: Epidemiologia and Mechanisms. Curr Opin Pulm Med. 2009; 15(5):408–412.
5. Levy AS, Eckardt KU, Tsukamoto Y, Knoyan G. Definition and classification of chronic kidney disease; A position statement from Kidney Disease; ImprovingGlobal Outcomes (KDIGO) Kidney Int. 2005;67(6):2089–2100.
6. Upadhyay A, Larson MG, Guo CY, Vasan RS, Lipinska I, ODonnell CJ, Kathiresan S, Meigs JB, Keaney JF, Rong J, Benjamin EJ, Fox CS. Inflamation, kidney funkcion and albuminuria in the Framingham Offspring cohort. Nephrol Dial Transplant. 2011; 26(3):920–926.
7. Vidt DG. Inflammation in renal disease. Am J Cardiol. 2006; 97:20A–27A.
8. Recio-Mayoral A, Banerjee D, Streather C, Kaski JC. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease-a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis. 2011;216(2):446–451.
9. Annuk M, Soveri I, Zilmer M, Lind L, Hulthe J, Fellstrom B. Endothelial function, CRP and oxidative stress in chronic kidney disease. J Nephrol. 2005;18(6):721–726.
10. Gupta J, Mitra N, Kanetsky PA, Devaney J, Wing MR, Reilly M, Shah VO, Balakrishnan VS, Guzman NJ, Girndt M, Periera BG, Feldman HI, Kusek JW, Joffe MM, Raj DS. Association betwen albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIS. Clin J Am Nephrol. 2012;7(12):1938–1946.

    file

    download